These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39316398)

  • 1. Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Gaither JR; Drago MJ; Grossman MR; Li Y; Shabanova V; Xu X; Leventhal JM
    JAMA Netw Open; 2024 Sep; 7(9):e2435074. PubMed ID: 39316398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Hospital Readmissions for Infants With Neonatal Opioid Withdrawal Syndrome, 2016-2019.
    Milliren CE; Melvin P; Ozonoff A
    Hosp Pediatr; 2021 Sep; 11(9):979-988. PubMed ID: 34417200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.
    Shrestha S; Roberts MH; Maxwell JR; Leeman LM; Bakhireva LN
    Neurotoxicol Teratol; 2021; 86():106975. PubMed ID: 33766722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
    Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
    JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
    Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant Mortality Associated With Prenatal Opioid Exposure.
    Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
    JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics.
    Schwartz AN; Meschke LL
    Arch Womens Ment Health; 2024 Oct; 27(5):863-867. PubMed ID: 38573341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
    Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
    Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring.
    Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
    J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Neonatal Opioid Withdrawal Syndrome and Opioid Exposure Diagnoses Among Infants With Private Health Insurance, 2016-2021: Introduction of the P04.14 ICD-10-CM Code.
    Campbell AG; Zhang P; Rosenman MB; Scott E; Wiehe SE
    Public Health Rep; 2024; 139(1):88-93. PubMed ID: 37119181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
    Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB
    Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
    Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
    Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Individual versus Community-level Social Vulnerability and Neonatal Opioid Withdrawal Syndrome among Pregnant Individuals Receiving Buprenorphine for Opioid Use Disorder.
    Mason I; Abdelwahab M; Stiles A; Wu J; Venkatesh KK; Rood KM
    Am J Perinatol; 2024 May; 41(S 01):e3157-e3163. PubMed ID: 37890511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome.
    MacMillan KDL; Morrison TM; Melvin P; Diop H; Gupta M; Wachman EM
    J Pediatr; 2022 Jun; 245():47-55. PubMed ID: 35131283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
    Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
    Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
    Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
    Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.